Michel Ducreux Selected Research

Michel Ducreux Research Topics

Disease

89	Neoplasms (Cancer) 05/2024 - 01/2002
59	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 09/2003
50	Neoplasm Metastasis (Metastasis) 06/2024 - 01/2003
20	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 12/2003
19	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023 - 06/2002
13	Adenocarcinoma 12/2023 - 01/2005
9	Disease Progression 06/2024 - 09/2006
9	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2024 - 07/2004
9	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 02/2002
8	Neutropenia 01/2021 - 01/2008
6	Rectal Neoplasms (Rectal Cancer) 01/2023 - 08/2005
6	Carcinoid Tumor (Carcinoid) 01/2019 - 02/2002
6	Stomach Neoplasms (Stomach Cancer) 01/2019 - 03/2004
5	Hypertension (High Blood Pressure) 01/2023 - 10/2016
5	Peritoneal Neoplasms 06/2013 - 04/2003
4	Carcinoma (Carcinomatosis) 10/2023 - 03/2011
4	Liver Neoplasms (Liver Cancer) 08/2023 - 02/2010
4	Microsatellite Instability 01/2023 - 09/2003
4	Cholangiocarcinoma 11/2022 - 01/2007
3	Diarrhea 05/2024 - 01/2019
3	Asthenia 01/2023 - 01/2012
3	Hemorrhage 12/2022 - 01/2012
3	Neuroendocrine Carcinoma 01/2021 - 04/2011
3	Pneumothorax 01/2019 - 08/2005
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 09/2006
3	Febrile Neutropenia 05/2011 - 01/2008
2	Fatigue 05/2024 - 01/2021
2	Intestinal Perforation 01/2023 - 06/2022
2	Heart Arrest (Cardiac Arrest) 01/2023 - 01/2019
2	Pain (Aches) 01/2021 - 11/2017
2	Brain Diseases (Brain Disorder) 01/2020 - 01/2019
2	Vomiting 01/2019 - 12/2013
2	Liver Diseases (Liver Disease) 02/2015 - 04/2007
2	Colonic Neoplasms (Colon Cancer) 12/2009 - 07/2006
1	Exanthema (Rash) 05/2024

Drug/Important Bio-Agent (IBA)

33	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 12/2003
29	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2002
21	Bevacizumab (Avastin)FDA Link 10/2023 - 08/2005
21	Irinotecan (Camptosar)FDA LinkGeneric 03/2022 - 11/2002
15	Leucovorin (Folinic Acid)FDA Link 12/2023 - 06/2002
14	Cetuximab (Erbitux)FDA Link 12/2023 - 04/2006
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2004
12	Gemcitabine FDA Link 01/2023 - 06/2002
11	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 06/2002
8	Sorafenib (BAY 43-9006)FDA Link 10/2023 - 10/2014
7	ErbB Receptors (EGF Receptor)IBA 12/2023 - 04/2006
7	atezolizumabIBA 10/2023 - 01/2020
6	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2009
6	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2021 - 02/2002
6	Monoclonal AntibodiesIBA 06/2019 - 05/2004
6	folfirinoxIBA 02/2019 - 05/2011
5	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2016
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 08/2005
4	regorafenibIBA 01/2023 - 12/2019
4	AntibodiesIBA 12/2022 - 08/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2008
3	Panitumumab (Vectibix)FDA Link 12/2023 - 11/2010
3	BilirubinIBA 10/2023 - 11/2002
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 08/2005
3	LigandsIBA 01/2023 - 11/2015
3	PlatinumIBA 01/2021 - 07/2004
3	VaccinesIBA 01/2021 - 01/2019
3	Chromogranin AIBA 01/2021 - 04/2011
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
3	Therapeutic UsesIBA 01/2017 - 02/2002
3	Docetaxel (Taxotere)FDA Link 10/2014 - 03/2004
3	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2013 - 01/2005
2	EnzymesIBA 05/2024 - 09/2005
2	Messenger RNA (mRNA)IBA 09/2023 - 01/2023
2	tislelizumabIBA 02/2023 - 06/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 10/2008
2	Phosphotransferases (Kinase)IBA 12/2022 - 01/2017
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 04/2021 - 01/2017
2	130-nm albumin-bound paclitaxelIBA 02/2019 - 01/2017
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 01/2017
2	Ethiodized Oil (Ethiodol)FDA Link 04/2015 - 03/2012
2	Transaminases (Aminotransferases)IBA 07/2014 - 01/2012
2	TOR Serine-Threonine KinasesIBA 01/2013 - 02/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2012 - 03/2012
2	Tyrosine Kinase InhibitorsIBA 08/2005 - 05/2004
2	Celecoxib (Celebrex)FDA Link 08/2005 - 07/2005

Therapy/Procedure

80	Drug Therapy (Chemotherapy) 06/2024 - 01/2003
55	Therapeutics 10/2023 - 06/2002
12	Radiotherapy 01/2023 - 08/2005
8	Immunotherapy 05/2024 - 01/2016
8	Precision Medicine 12/2023 - 12/2017
8	Radiofrequency Ablation 01/2019 - 04/2002
7	Hepatectomy 11/2023 - 04/2003
7	Chemoradiotherapy 10/2023 - 10/2006
6	Neoadjuvant Therapy 10/2023 - 01/2019
5	Hyperthermic Intraperitoneal Chemotherapy 01/2018 - 01/2005
5	Combination Drug Therapy (Combination Chemotherapy) 01/2016 - 01/2005
4	Adjuvant Chemotherapy 01/2023 - 01/2013
3	Cytoreduction Surgical Procedures 01/2018 - 06/2013
2	Molecular Targeted Therapy 03/2021 - 01/2019
2	Combined Modality Therapy 01/2021 - 01/2019
2	Electrodes (Electrode) 07/2006 - 08/2005
2	Contraindications 11/2005 - 03/2004
1	Transplantation 06/2024
1	Liver Transplantation 06/2024